You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):子公司口服液體一車間的口服液體制劑2線(糖漿劑)通過藥品GMP符合性檢查
格隆匯 09-08 17:08

格隆匯9月8日丨國藥現代(600420.SH)公佈,近日,公司控股子公司國藥集團致君(深圳)坪山製藥有限公司(“致君坪山”)通過了廣東省藥品監督管理局的藥品GMP符合性檢查,認定次檢查範圍“糖漿劑”符合《藥品生產質量管理規範(2010年修訂)》要求。此次檢查通過後,致君坪山相應完成了藥品生產許可證的變更工作。

次GMP符合性檢查為口服液體一車間在現有口服液體制劑2線上新增糖漿劑生產範圍,通過後該生產線將可以生產口服溶液劑和糖漿劑兩個劑型的產品,該車間上述認證項目是在原有廠房、設備情況下的增加生產劑型,無相關工程費用投入。

根據米內網數據顯示,2020年地氯雷他定糖漿在全國城市公立醫院銷售額為人民幣1876.00萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account